50
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Biochemical characterization of the interactions between doxorubicin and lipidic GM1 micelles with or without paclitaxel loading

, , , , &
Pages 3377-3388 | Published online: 06 May 2015

References

  • RiveraEValeroVArunBPhase II study of pegylated liposomal doxorubicin in combination with gemcitabine in patients with metastatic breast cancerJ Clin Oncol2003213249325412947059
  • ShahJJOrlowskiRZThomasSKRole of combination bortezomib and pegylated liposomal doxorubicin in the management of relapsed and/or refractory multiple myelomaTher Clin Risk Manag2009515115919436606
  • SwensonCEBolcsakLEBatistGPharmacokinetics of doxorubicin administered i.v. as myocet (TLC D-99; liposome-encapsulated doxorubicin citrate) compared with conventional doxorubicin when given in combination with cyclophosphamide in patients with metastatic breast cancerAnticancer Drugs200314323924612634619
  • CuongNVHsiehMFRecent advances in pharmacokinetics of polymeric excipients used in nanosized anti-cancer drugsCurr Drug Metab20091084285020214579
  • HaranGCohenRBarLKBarenholzYTransmembrane ammonium sulfate gradients in liposomes produce efficient and stable entrapment of amphipathic weak basesBiochim Biophys Acta1993115122012158373796
  • KwonGNaitoMYokoyamaMOkanoTSakuraiYKataokaKBlock copolymer micelles for drug delivery: loading and release of doxorubicinJ Control Release1997482–3195201
  • ChenWMengFChengRZhongZpH-sensitive degradable polymersomes for triggered release of anticancer drugs: a comparative study with micellesJ Control Release19971421404619804803
  • KimJOKabanovAVBronichTKPolymer micelles with cross-linked polyanion core for delivery of a cationic drug doxorubicinJ Control Release2009138319720419386272
  • TorchilinVRecent advances with liposomes as pharmaceutical carriersNat Rev Drug Discov20054214516015688077
  • KakizawaYKataokaKBlock copolymer micelles for delivery of gene and related compoundsAdv Drug Deliv Rev200254220322211897146
  • YokoyamaMPolymeric micelles as a new drug carrier system and their required considerations for clinical trialsExpert Opin Drug Deliv20107214515820095939
  • AminCMackmanNKeyNSMicroparticles and cancerPathophysiol Haemost Thromb2008363–417718319176990
  • LeonhardVAlasinoRVBiancoIDGarroAGHerediaVBeltramoDMSelf-assembled micelles of gangliosides as nanodelivery vehicles of taxanesJ Control Release2012162361962722877735
  • LeonhardVBeltramoDMAlasinoRVBiancoIDinventorConicet-Consejo NacDe Investigaciones Científicas Y Técnicas, Ceprocor – Centro De Excelencia En Prod. Y Procesos De Córdoba, assignee. Water-soluble pharmaceutical composition comprising at least one therapeutically active substance having hydrophobic properties and at least one compound selected from among sialoglycosphingolipids, glycosphingolipids or a mixture of sialoglycosphingolipids and glycosphingolipidsPatentWO/2011/1139812011922
  • LeonhardVAlasinoRVBiancoIDGarroAGHerediaVBeltramoDMSelective binding of albumin to gm1 ganglioside micelles containing paclitaxelJ Nanomed Nanotechnol20124159
  • GradisharWJAlbumin-bound paclitaxel: A next-generation taxaneExpert Opin Pharmacother200671041105316722814
  • Fukunaga-KalabisMHerlynMUnraveling mysteries of the multifunctional protein SPARCJ Invest Dermatol20071272497249817934501
  • MiettinenTTakki-LuukkainenITUse of butyl acetate in determination of sialic acidActa Chem Scand195913856858
  • AbrahamSAEdwardsKKarlssonGFormation of transition metal-doxorubicin complexes inside liposomesBiochim Biophys Acta200215651415412225851
  • GarroAGBeltramoDMAlasinoRVLeonhardVHerediaVBiancoIDReversible exposure of hydrophobic residues on albumin as a novel strategy for the formulation of nanodelivery vehicles of taxanesInt J Nanomedicine201161193120021822381
  • Ulrich-BottBWiegandtHMicellar properties of glycosphingolipids in aqueous mediaJ Lipid Res198425123312456520543
  • SonninoSCantúLCortiMAcquottiDVenerandoBAggregative properties of gangliosides in solutionChem Phys Lipids19947121458039256
  • MaggioBAlbertJYuRKThermodynamic-geometric correlations for the morphology of self-assembled structures of glycosphingolipids and their mixtures with dipalmitoylphosphatidylcholineBiochim Biophys Acta198894521451603191118
  • TardiPGBomanNICullisPRReview Liposomal DoxorubicinJ Drug Target1996431291408959485
  • CantúLCortiMDel FaveroEMullerERaudinoASonninoSThermal hysteresis in ganglioside micelles investigated by differential scanning calorimetry and light-scatteringLangmuir19991549754980
  • OrthaberDGlatterOTime and temperature dependent aggregation behaviour of the ganglioside GM1 in aqueous solutionChem Phys Lipids199892153629631537
  • HiraiMTakizawaTIntensive extrusion and occlusion of water in ganglioside micelles with thermal reversibilityBiophys J199874301030149635755
  • HayakawaTHiraiMHydration and thermal reversibility of glycolipids depending on sugar chainsEur Biophys J2002311627212046898
  • WallevikKHvidtAConformational changes in human serum albumin as revealed by Hydrogen-Deuterium Exchange StudiesJ Biol Chem1972247153015355012322
  • El KadiNTaulierNLe HuérouJYUnfolding and refolding of bovine serum albumin at acid pH: ultrasound and structural studiesBiophys J20069193397340416861279
  • MuzammilSKumarYTayyabSMolten globule-like state of human serum albumin at low pHEur J Biochem1999266263210542047
  • UzielyBJeffersSIsacsonRLiposomal doxorubicin: antitumor activity and unique toxicities during two complementary phase I studiesJ Clin Oncol199513177717857602367
  • LotemMHubertALyassOSkin toxic effects of polyethylene glycol-coated liposomal doxorubicinArch Dermatol20001361475148011115157
  • ElbayoumiTATorchilinVPTumor-specific antibody-mediated targeted delivery of DoxilR reduces the manifestation of auricular erythema side effect in miceInt J Pharm200835727227918329201
  • KimDGaoZGLeeESBaeYHIn vivo evaluation of doxorubicin-loaded polymeric micelles targeting folate receptors and early endosomal pH in drug-resistant ovarian cancerMol Pharm2009651353136219507896
  • KimDLeeESOhKTGaoZGBaeYHDoxorubicin-loaded polymeric micelle overcomes multidrug resistance of cancer by double-targeting folate receptor and early endosomal pHSmall20084112043205018949788
  • LeeESDoxorubicin loaded pH-sensitive polymeric micelles for reversal of resistant MCF-7 tumorJ Control Release2005103240541815763623
  • CuongNVJiangJLLiYLChenJRJwoSCHsiehMFDoxorubicin-loaded PEG-PCL-PEG micelle using xenograft model of nude mice: effect of multiple administration of micelle on the suppression of human breast cancerCancers20113617824212606
  • DubeNShuJYDongHEvaluation of doxorubicin-loaded 3-helix micelles as nanocarriersBiomacromolecules201314103697370024050265
  • DuanXXiaoJYinQSmart pH-sensitive and temporal-controlled polymeric micelles for effective combination therapy of doxorubicin and disulfiramACS Nano2013775858586923734880
  • GuoXShiCYangGWangJCaiZZhouSDual-responsive polymer micelles for target-cell-specific anticancer drug deliveryChem Mater2014261544054418
  • Ruiz-HernándezEHessMMelenGJPEG-pHPMAm-based polymeric micelles loaded with doxorubicin-prodrugs in combination antitumor therapy with oncolytic vaccinia virusesPolym Chem201451674168124518685
  • AllenTMChonnALarge unilamellar liposomes with low uptake into the reticuloendothelial systemFEBS Lett198722342463666140
  • GabizonAPapahadjopoulosDLiposome formulations with prolonged circulation time in blood and enhanced uptake by tumorsProc Natl Acad Sci U S A198885694969533413128
  • CantuLCortiMAcquottiDSonninoSAggregation properties of gangliosides: influence of the primary and secondary structure of the headgroupJ Phys IV19933C15764
  • IbrahimNKDesaiNLeghaSPhase I and pharmacokinetic study of ABI-007, a Cremophor-free, protein-stabilized, nanoparticle formulation of paclitaxelClin Cancer Res200281038104412006516
  • HayashiKTatsuiTShimanouchiTUmakoshiHEnhanced cytotoxicity for colon 26 cells using doxorubicin-loaded sorbitan monooleate (Span 80) vesiclesInt J Biol Sci20139214214823411680
  • NieYJiLDingHCholesterol derivatives based charged liposomes for doxorubicin delivery: preparation, in vitro and in vivo characterizationTheranostics20122111092110323227125